ADJUVANT THERAPY
Clinical trials for ADJUVANT THERAPY explained in plain language.
Never miss a new study
Get alerted when new ADJUVANT THERAPY trials appear
Sign up with your email to follow new studies for ADJUVANT THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to stop high-risk breast cancer recurrence
Disease control Recruiting nowThis study tests whether adding a CDK4/6 inhibitor to standard hormone therapy can help prevent breast cancer from returning in people with a high-risk type called HR+/HER2+. About 1,900 participants who have already completed initial treatment will be followed for 5 years. The g…
Matched conditions: ADJUVANT THERAPY
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
New combo therapy aims to keep aggressive breast cancer from returning
Disease control Recruiting nowThis study tests whether adding the drug QL1706 to standard chemotherapy after surgery can help prevent cancer from coming back in people with high-risk triple-negative breast cancer. About 59 participants will receive up to 8 cycles of chemo plus QL1706, followed by up to 17 cyc…
Matched conditions: ADJUVANT THERAPY
Phase: NA • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC